£69.55

Südwestdeutscher Verlag für Hochschulschriften Somatic alterations in critical genes in malignant melanoma: Effect on global gene expression

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£70 today · all-time low £68 (Jun 2024) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 627 days • 627 data points (No recent data available)

Historical
Generating forecast...
£71.00 £67.68 £68.40 £69.13 £69.85 £70.58 £71.30 12 June 2024 15 November 2024 21 April 2025 24 September 2025 28 February 2026

Price Distribution

Price distribution over 627 days • 4 price levels

Days at Price
Current Price
59 days 13 days 12 days · current 543 days 0 136 272 407 543 £68 £69 £70 £71 Days at Price

Price Analysis

Most common price: £71 (543 days, 86.6%)

Price range: £68 - £71

Price levels: 4 different prices over 627 days

Description

Melanoma is the most aggressive skin tumour and the number of cases and deaths has increased faster than many other cancers. Activating mutations in the B-RAF and N-RAS proto-oncogenes and deletion of the tumour suppressor gene CDKN2A occur at high frequencies in melanomas. This study characterises the widely unknown consequences of the most prominent somatic alterations in the B-RAF, N-RAS, and CDKN2A genes on gene expression in melanoma. Additionally, the effect of the V600E B-RAF mutation on gene expression in benign melanocytic nevi, known precursors of melanoma, was examined. In summary, the studied alterations significantly influence expression of various genes in the RAS-RAF-MEK-ERK, Rb, and PI3K/AKT pathways. MAPK pathway activation occurs in the early stages of melanocyte transformation, antagonised by several tumour suppressing mechanisms. Among others, CDKN1C was identified as novel gene, whose loss most likely constitutes a second genetic ´hit´ required for melanoma progression. Besides new therapeutic targets to treat melanoma patients, the data may encode new markers for early recognition of individuals with increased risk for development of malignant melanoma.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)
97% match

BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)

Humana

£75.80 01 Mar 2026
WHO Classification of Skin Tumours: WHO Classification of Tumours, Volume 11 (World Health Organization classification of tumours)
97% match

WHO Classification of Skin Tumours: WHO Classification of Tumours, Volume 11 (World Health Organization classification of tumours)

World Health Organization

£104.82 18 Feb 2026
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)
97% match

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)

Humana

£155.65 24 Jan 2026
Melanoma: 167 (Cancer Treatment and Research, 167)
97% match

Melanoma: 167 (Cancer Treatment and Research, 167)

Springer

£102.99 15 Apr 2026
The Intersection of Dermatology and Oncology, An Issue of Dermatologic Clinics (Volume 37-4) (The Clinics: Dermatology, Volume 37-4)
97% match

The Intersection of Dermatology and Oncology, An Issue of Dermatologic Clinics (Volume 37-4) (The Clinics: Dermatology, Volume 37-4)

Elsevier

£67.70 12 Apr 2026
Molecular Diagnostics for Melanoma: Methods and Protocols: 1102 (Methods in Molecular Biology, 1102)
97% match

Molecular Diagnostics for Melanoma: Methods and Protocols: 1102 (Methods in Molecular Biology, 1102)

Humana

£54.12 12 Jan 2026
New Therapies in Advanced Cutaneous Malignancies
97% match

New Therapies in Advanced Cutaneous Malignancies

Springer

£73.87 09 Feb 2026
MELANOMA MOLECULAR BIOLOGY: Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis and Treatments: Dermatology - Laboratory and Clincal Research)
97% match

MELANOMA MOLECULAR BIOLOGY: Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis and Treatments: Dermatology - Laboratory and Clincal Research)

£84.96 09 Mar 2026
Human Melanoma: From Basic Research to Clinical Application
97% match

Human Melanoma: From Basic Research to Clinical Application

Springer

£77.19 07 Mar 2026
Oncodermatology: An Evidence-Based, Multidisciplinary Approach to Best Practices
97% match

Oncodermatology: An Evidence-Based, Multidisciplinary Approach to Best Practices

£108.16 11 Jan 2026
Non-melanoma Skin Cancer: Essentials for Oncologists (Series in Medical Physics and Biomedical Engineering)
97% match

Non-melanoma Skin Cancer: Essentials for Oncologists (Series in Medical Physics and Biomedical Engineering)

CRC Press

£112.08 08 Mar 2026
Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America (Volume 38-5) (The Clinics: Internal Medicine, Volume 38-5)
97% match

Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America (Volume 38-5) (The Clinics: Internal Medicine, Volume 38-5)

Elsevier

£10.74 05 Mar 2026
Melanoma, An Issue of Clinics in Plastic Surgery (Volume 48-4) (The Clinics: Surgery, Volume 48-4)
97% match

Melanoma, An Issue of Clinics in Plastic Surgery (Volume 48-4) (The Clinics: Surgery, Volume 48-4)

Elsevier

£76.97 10 Apr 2026
Skin Cancer (Site-specific Cancer Series)
96% match

Skin Cancer (Site-specific Cancer Series)

Oncology Nursing Society

£25.00 22 Feb 2026
The Moss Report - Skin Cancer: MelanomaTreatment Guide
96% match

The Moss Report - Skin Cancer: MelanomaTreatment Guide

£62.26 08 Mar 2026
Cutaneous Melanoma, Fifth Edition
96% match

Cutaneous Melanoma, Fifth Edition

Routledge

£237.48 23 Jan 2026
Genetics of Melanoma (Cancer Genetics)
96% match

Genetics of Melanoma (Cancer Genetics)

Springer

£78.95 08 Mar 2026
Targeted Therapeutics in Melanoma (Current Clinical Oncology)
96% match

Targeted Therapeutics in Melanoma (Current Clinical Oncology)

Humana

£80.27 19 Apr 2026
Melanocytic Tumors of the Skin (AFIP Atlas of Tumor Pathology, Series 4,)
96% match

Melanocytic Tumors of the Skin (AFIP Atlas of Tumor Pathology, Series 4,)

£109.16 21 Jan 2026
Pathology of Melanocytic Nevi and Melanoma
96% match

Pathology of Melanocytic Nevi and Melanoma

Springer

£118.33 15 Apr 2026
Cancers of the Skin: Proceedings of the 8th World Congress: 160 (Recent Results in Cancer Research, 160)
96% match

Cancers of the Skin: Proceedings of the 8th World Congress: 160 (Recent Results in Cancer Research, 160)

Springer

£149.87 01 Apr 2026
McKee's Pathology of the Skin - 2 volume set
96% match

McKee's Pathology of the Skin - 2 volume set

Elsevier

£311.99 27 Jan 2026
Non-Surgical Treatment of Keratinocyte Skin Cancer
96% match

Non-Surgical Treatment of Keratinocyte Skin Cancer

Springer

£100.23 24 Feb 2026
Melanoma, An Issue of Hematology/Oncology Clinics of North America: Volume 35-1 (The Clinics: Internal Medicine, Volume 35-1)
96% match

Melanoma, An Issue of Hematology/Oncology Clinics of North America: Volume 35-1 (The Clinics: Internal Medicine, Volume 35-1)

Elsevier

£68.70 18 Apr 2026